Quest Diagnostics (DGX) Operating Leases (2019 - 2026)

Quest Diagnostics has disclosed Operating Leases across 8 years of filings, most recently posting $574.0 million for Q1 2026.

• Operating Leases for Q1 2026 came in at $574.0 million, up 6.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $574.0 million (up 6.69% YoY), and the FY2025 annual result was $537.0 million, down 25.93% from the prior year.
• Operating Leases came in at $574.0 million for Q1 2026 at Quest Diagnostics, up from $537.0 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $725.0 million in Q4 2024 to a low of $489.0 million in Q4 2022.
• The 5-year median for Operating Leases is $508.0 million (2023), against an average of $529.8 million.
• Across the five-year window, Operating Leases fell 27.98% in 2022 and surged 44.14% in 2024, its largest moves.
• Quest Diagnostics' Operating Leases stood at $489.0 million in 2022, then rose by 2.86% to $503.0 million in 2023, then jumped by 44.14% to $725.0 million in 2024, then dropped by 25.93% to $537.0 million in 2025, then grew by 6.89% to $574.0 million in 2026.
• The last three Operating Leases figures came in at $574.0 million (Q1 2026), $537.0 million (Q4 2025), and $534.0 million (Q3 2025), per Business Quant data.